Caregivers represent an integral part of patient care, yet their vital role is easily overlooked, and they often lack the informational support needed to provide optimal care for patients. For National Caregiver Month (November), Prime Patient explores how pharmaceutical companies can become “caregiver champions” by recognising the essential nature of carers’ roles and providing much needed educational support services (1).read more >>
Putting patients at the heart of the drug development process to deliver value and improve outcomes
Deliver more value and improve patient outcomes by making sure that the patient voice is heard throughout the development journey. Our People First ethos means exactly that; let us help you put patients at the heart of your drug development process.
From insights to engagement strategy, market access to education, and even clinical trials, we’ll support you every step of the way.
Patient Engagement Strategy
Need a big-picture view of how to engage with patients and deliver on your patient-centricity journey? Our experienced teams help you build the strategic foundations and planning for effective communication programs and identify opportunities to embed patient-centricity within your organisation.
From high-level strategic review and recommendations, to foundational strategic deliverables such as persona development and patient experience mapping, we help you guide and develop a truly patient-centric approach.
Want to understand more about your patients to help improve their outcomes and deliver more value? We can support you to discover their wants and needs, identify market trends, engage with opinion leaders to extend your reach, and more.
We conduct all types of market research to inform your activities, from in-depth qualitative and quantitative methodologies to social listening.
The patient experience of clinical trials is key to successful planning and delivery. Let us help you understand the patient voice to inform research priorities, develop protocols, recruit patients, and encourage adherence.
Deliver improved outcomes by putting patients at the heart; get the right content, in the right format, to the right audience, via the right channel, at the right time.
Our teams have years of experience in identifying the value, building engaging platforms, and connecting with your audience for effective multichannel patient education programs.
Build the patient voice into your market access workstreams and ensure the patient voice is heard. We support you to create and deliver truly patient-centric market access strategies, real world evidence generation, value communications, and engagement programs.
Incorporating the patient voice throughout the whole drug development process is no longer a nice-to-have, it’s a must. Patient engagement helps deliver a triple win for patients, pharma, and society.
At the forefront of innovation in patient engagement.
Patient engagement and insight at the heart of everything we do:
Creating the value exchange
Content strategy, value exchange, materials, education programs
Delivering a home for your patients
Patient-facing websites, app development and ecosystems
Connecting your services with patients
Multichannel engagement strategy and implementation programs
Want to find out more? Contact us today using the link below or email email@example.com
Prime Patient News.
Caregiver education and Pharma should always go hand-in-hand: Here’s why!Prime Global 8 December, 2022
Breast cancer treatment: decision-making through a health literacy lensPrime Global 25 October, 2022
In recognition of both Health Literacy Month and Breast Cancer Awareness Month, we’re looking at the unmet treatment education needs of people living with breast cancer who experience low health literacy.
Patient-reported outcomes in metastatic breast cancer: delivering multistakeholder value through patient centricityPrime Global 13 October, 2022
October is World Breast Cancer Awareness Month, and 13 October is Metastatic Breast Cancer Awareness Day. Let’s look at how the views of people living with metastatic breast cancer provide a vital, underestimated component of assessing the benefits of novel treatments.